COMPANY PROFILE

Bovie Medical Corp. is a leading maker of medical devices and supplies as well as the developer of J-Plasma®, a patented plasma-based surgical product. J-Plasma® utilizes a gas ionization process that produces a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents through the patient during surgery. J-Plasma®, still in the early stages of commercialization, has the potential to be a transformational product for surgeons.

Bovie Medical is also a leader in the manufacture of a range of electrosurgical products and technologies. These are marketed through both private labels and Bovie’s own well-respected brands (Bovie®, Aaron®, IDS™ and ICON™) to distributors worldwide. The Company also leverages its expertise through original equipment manufacturing (OEM) agreements with other medical device manufacturers.

CORPORATE INFORMATION

Bovie Medical Corporation
5115 Ulmerton Road • Clearwater, FL 33760-4004 • USA
Ph +1 727 384 2323

BOARD OF DIRECTORS

Andrew Makrides, Esq., Executive Chairman of the Board of Directors | Bio
Charles D. Goodwin, Chief Executive Officer & Director | Bio
John Andres, Director | Bio
Michael Geraghty
, Director | Bio
J. Robert Saron, President & Director | Bio
Craig A. Swandal, Director | Bio
Lawrence J. Waldman, CPA, Director | Bio

NEWS & PRESS RELEASES

LATEST NEWS

NEWS & PRESS RELEASE ARCHIVE

2018  |  2017  |  2016  |  2015  |  2014  |  2013  |  2012  |  2011  |  2010

                                        PDF DOWNLOADS

COMPANY PRESENTATIONS

COMPANY EVENTS

PowerPoint Presentation
adobestock_95532392-new_home-ir-image_318x160

Management hosted a conference call on May 14 to discuss the results of the quarter. To listen to a replay of the call, click the button below.

home_currenteventsthumb

Bovie Medical Corporation will participate in the following conference. To listen to the live webcast, click the button below.

JMP Securities 2018 Life Science Conference at the St. Regis New York in New York, New York. Management will participate in a fireside chat with investors on Wednesday, June 20 at 12:30 p.m. Eastern Time.

otherevents_graphic

QUARTERLY RESULTS

RESULTS

SUPPLEMENTALS

ANNUAL REPORTS

ANNUAL REPORTS

OTHER FILINGS

PROXY

XBRL FILINGS

2017

Filing Date: 03/13/2018 | Form Type: 10-K | Description: FORM 10-K for the period ended December 31, 2017          XBRL | PDF | Link to SEC

Filing Date: 11/03/2017 | Form Type: 10-Q | Description: FORM 10-Q for the period ended September 30, 2017          XBRL | PDF | Link to SEC

Filing Date: 08/03/2017 | Form Type: 10-Q | Description: FORM 10-Q for the period ended June 30, 2017          XBRL | PDF | Link to SEC

Filing Date: 05/15/2017 | Form Type: 10-Q | Description: FORM 10-Q for the period ended March 31, 2017          XBRL | PDF | Link to SEC

2016

Filing Date: 03/10/2017 | Form Type: 10-K | Description: FORM 10-K FOR THE PERIOD ENDED DECEMBER 31, 2016           XBRL | PDF | Link to SEC

Filing Date: 10/27/2016 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2016           XBRL | PDF | Link to SEC

Filing Date: 08/01/2016 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2016           XBRL | PDF | Link to SEC

Filing Date: 05/11/2016 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 2016           XBRL | PDF | Link to SEC

Filing Date: 03/18/2016 | Form Type: 10-K | Description: FORM 10-K FOR THE PERIOD ENDED DECEMBER 31, 2015          XBRL | PDF | Link to SEC

2015

Filing Date: 11/5/2015 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2015           XBRL | PDF | Link to SEC

Filing Date: 08/7/2015 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2015          XBRL | PDF | Link to SEC

Filing Date: 05/8/2015 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 2015           XBRL | PDF | Link to SEC

Filing Date: 02/27/2015 | Form Type: 10-K | Description: FORM 10-K FOR THE PERIOD ENDED DECEMBER 31, 2014         XBRL | PDF | Link to SEC 

2014

Filing Date: 11/10/2014 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2014           XBRL | PDF | Link to SEC

Filing Date: 08/8/2014 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2014          XBRL | PDF | Link to SEC

Filing Date: 05/15/2014 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 2014           XBRL | PDF | Link to SEC

Filing Date: 05/15/2014 | Form Type: 10-K/A | Description: FORM 10-K/A FOR THE PERIOD ENDED DECEMBER 31, 2013         XBRL | PDF | Link to SEC 

Filing Date: 03/31/2014 | Form Type: 10-K | Description: FORM 10-K FOR THE PERIOD ENDED DECEMBER 31, 2013         XBRL | PDF | Link to SEC 

2013

Filing Date: 11/14/2013 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2013          XBRL | PDF | Link to SEC

Filing Date: 09/25/2013 | Form Type: 10-Q/A | Description: FORM 10-Q/A FOR THE PERIOD ENDED JUNE 30, 2013         XBRL | PDF | Link to SEC

Filing Date: 08/14/2013 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2013           XBRL | PDF | Link to SEC

Filing Date: 05/15/2013 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 2013         XBRL  | Link to SEC

Filing Date: 04/1/2013 | Form Type: 10-K | Description: FORM 10-K FOR THE PERIOD ENDED DECEMBER 31, 2012         XBRL  | Link to SEC

2012

Filing Date: 11/14/2012 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2012          XBRL  | Link to SEC

Filing Date: 08/14/2012 | Form Type: 10-Q/A | Description: FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2012         XBRL  | Link to SEC

Filing Date: 05/15/2012 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 2012          XBRL  | Link to SEC

Filing Date: 03/29/2012 | Form Type: 10-K | Description: FORM 10-K FOR THE PERIOD ENDED DECEMBER 31, 2011         XBRL  | Link to SEC

2011

Filing Date: 11/14/2011 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2011          XBRL  | Link to SEC

Filing Date: 08/12/2011 | Form Type: 10-Q/A | Description: FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2011         XBRL  | Link to SEC

INVESTOR CONTACT

Executive Offices: Bovie Medical Corporation
4 Manhattanville Road  |  Purchase, NY 10577 • USA
Ph +1-914-468-4070

United States Headquarters: Bovie Medical Corporation
5115 Ulmerton Road  |  Clearwater, FL 33760-4004 • USA
Ph +1-727-384-2323

INVESTOR INQUIRIES:
investor.relations@boviemedical.com

TRANSFER AGENT CONTACT:
investor.relations@boviemedical.com

CORPORATE GOVERNANCE

Top